ABOUT GSCHR-2027
The Leading Platform for Cannabis & Hemp Research
Three days of science, collaboration and plant innovation in Paris, France — October 18–20, 2027.
A MESSAGE FROM THE COMMITTEE
Welcome to GSCHR-2027
On behalf of the Committee, we invite all participants from every part of the world to attend GSCHR-2027, held October 18–20, 2027 in Paris, France. GSCHR-2027 is the leading meeting dedicated to Cannabis and Hemp Research, bringing together the global conversation on “Emerging Perspectives in Cannabis and Hemp Research.”
GSCHR-2027 is an annual meeting of Cannabis and Hemp Research committees exploring the future of the field — in terms of collaboration, structures, organizational development and the advancement of Cannabis and Hemp Research.
We cordially welcome researchers, academicians, business delegates, scholars and students to participate on this global platform and showcase their research work. GSCHR-2027 is a consortium of the scientific fraternity, scholars, educationists, industry leaders and entrepreneurs collaborating to resolve challenges across Cannabis and Hemp Research.
Foundational & Cutting-Edge Research, Together
GSCHR-2027 covers a wide range of subjects across Cannabis, Hemp and emerging research fields.
Why GSCHR-2027 Exists
Share Knowledge
A platform for presenting peer-reviewed research across the full spectrum of cannabis and hemp science.
Build Collaboration
Connecting researchers, academicians, growers and industry leaders to resolve shared challenges.
Drive Real Outcomes
Translating emerging research into practices that improve patient care and sustainable cultivation alike.
THE PROGRAM
An Expanded Scientific Program
GSCHR-2027 has expanded upon previous years’ meetings, opening up several more categories for its scientific sessions — making this meeting bigger and even more exciting than its predecessors.
The program involves discussion of specific topics in Cannabis and Hemp Research, including cannabinoids in epilepsy, hemp chemotypes, cannabinoid and terpene profiling, cannabis use disorder, cardiovascular and respiratory effects, and hemp phytoremediation.